nach oben

Erschienen in:

09.05.2018 | Original Paper

Cardiac magnetic resonance assessment of central and peripheral vascular function in patients undergoing renal sympathetic denervation as predictor for blood pressure response

verfasst von: Karl Fengler, Karl-Philipp Rommel, Stephan Blazek, Maximilian Von Roeder, Christian Besler, Christian Lücke, Matthias Gutberlet, Jennifer Steeden, Michael Quail, Steffen Desch, Holger Thiele, Vivek Muthurangu, Philipp Lurz

Erschienen in: Clinical Research in Cardiology | Ausgabe 10/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Most trials regarding catheter-based renal sympathetic denervation (RDN) describe a proportion of patients without blood pressure response. Recently, we were able to show arterial stiffness, measured by invasive pulse wave velocity (IPWV), seems to be an excellent predictor for blood pressure response. However, given the invasiveness, IPWV is less suitable as a selection criterion for patients undergoing RDN. Consequently, we aimed to investigate the value of cardiac magnetic resonance (CMR) based measures of arterial stiffness in predicting the outcome of RDN compared to IPWV as reference.

Methods

Patients underwent CMR prior to RDN to assess ascending aortic distensibility (AAD), total arterial compliance (TAC), and systemic vascular resistance (SVR). In a second step, central aortic blood pressure was estimated from ascending aortic area change and flow sequences and used to re-calculate total arterial compliance (cTAC). Additionally, IPWV was acquired.

Results

Thirty-two patients (24 responders and 8 non-responders) were available for analysis. AAD, TAC and cTAC were higher in responders, IPWV was higher in non-responders. SVR was not different between the groups. Patients with AAD, cTAC or TAC above median and IPWV below median had significantly better BP response. Receiver operating characteristic (ROC) curves predicting blood pressure response for IPWV, AAD, cTAC and TAC revealed areas under the curve of 0.849, 0.828, 0.776 and 0.753 (p = 0.004, 0.006, 0.021 and 0.035).

Conclusions

Beyond IPWV, AAD, cTAC and TAC appear as useful outcome predictors for RDN in patients with hypertension. CMR-derived markers of arterial stiffness might serve as non-invasive selection criteria for RDN.

Nur mit Berechtigung zugänglich

Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, Kapelak B, Walton A, Sievert H, Thambar S, Abraham WT, Esler M (2009) Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 373(9671):1275–1281. https://doi.org/10.1016/S0140-6736(09)60566-3 CrossRefPubMed

Desch S, Okon T, Heinemann D, Kulle K, Rohnert K, Sonnabend M, Petzold M, Muller U, Schuler G, Eitel I, Thiele H, Lurz P (2015) Randomized sham-controlled trial of renal sympathetic denervation in mild resistant hypertension. Hypertension 65(6):1202–1208. https://doi.org/10.1161/HYPERTENSIONAHA.115.05283 CrossRefPubMed

Azizi M, Sapoval M, Gosse P, Monge M, Bobrie G, Delsart P, Midulla M, Mounier-Vehier C, Courand PY, Lantelme P, Denolle T, Dourmap-Collas C, Trillaud H, Pereira H, Plouin PF, Chatellier G, Renal Denervation for Hypertension i (2015) Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial. Lancet 385(9981):1957–1965. https://doi.org/10.1016/S0140-6736(14)61942-5 CrossRefPubMed

Fengler K, Heinemann D, Okon T, Rohnert K, Stiermaier T, von Roder M, Besler C, Muller U, Hollriegel R, Schuler G, Desch S, Lurz P (2016) Renal denervation improves exercise blood pressure: insights from a randomized, sham-controlled trial. Clin Res Cardiol 105(7):592–600. https://doi.org/10.1007/s00392-015-0955-8 CrossRefPubMed

Bhatt DL, Kandzari DE, O’Neill WW, D’Agostino R, Flack JM, Katzen BT, Leon MB, Liu M, Mauri L, Negoita M, Cohen SA, Oparil S, Rocha-Singh K, Townsend RR, Bakris GL, Investigators SH- (2014) A controlled trial of renal denervation for resistant hypertension. N Engl J Med 370(15):1393–1401. https://doi.org/10.1056/NEJMoa1402670 CrossRefPubMed

Mahfoud F, Bohm M, Azizi M, Pathak A, Durand Zaleski I, Ewen S, Tsioufis K, Andersson B, Blankestijn PJ, Burnier M, Chatellier G, Gafoor S, Grassi G, Joner M, Kjeldsen SE, Luscher TF, Lobo MD, Lotan C, Parati G, Redon J, Ruilope L, Sudano I, Ukena C, van Leeuwen E, Volpe M, Windecker S, Witkowski A, Wijns W, Zeller T, Schmieder RE (2015) Proceedings from the European clinical consensus conference for renal denervation: considerations on future clinical trial design. Eur Heart J 36(33):2219–2227. https://doi.org/10.1093/eurheartj/ehv192 CrossRefPubMed

Townsend RR, Mahfoud F, Kandzari DE, Kario K, Pocock S, Weber MA, Ewen S, Tsioufis K, Tousoulis D, Sharp ASP, Watkinson AF, Schmieder RE, Schmid A, Choi JW, East C, Walton A, Hopper I, Cohen DL, Wilensky R, Lee DP, Ma A, Devireddy CM, Lea JP, Lurz PC, Fengler K, Davies J, Chapman N, Cohen SA, DeBruin V, Fahy M, Jones DE, Rothman M, Bohm M, investigators* SH-OMt (2017) Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial. Lancet 390(10108):2160–2170. https://doi.org/10.1016/S0140-6736(17)32281-X CrossRefPubMed

Fengler K, Rommel KP, Okon T, Schuler G, Lurz P (2016) Renal sympathetic denervation in therapy resistant hypertension—pathophysiological aspects and predictors for treatment success. World J Cardiol 8(8):436–446. https://doi.org/10.4330/wjc.v8.i8.436 CrossRefPubMedPubMedCentral

Laurent S, Boutouyrie P, Asmar R, Gautier I, Laloux B, Guize L, Ducimetiere P, Benetos A (2001) Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 37(5):1236–1241CrossRefPubMed

10.

Maroules CD, Khera A, Ayers C, Goel A, Peshock RM, Abbara S, King KS (2014) Cardiovascular outcome associations among cardiovascular magnetic resonance measures of arterial stiffness: the Dallas heart study. J Cardiovasc Magn Reson 16:33. https://doi.org/10.1186/1532-429X-16-33 CrossRefPubMedPubMedCentral

11.

Pettersen KH, Bugenhagen SM, Nauman J, Beard DA, Omholt SW (2014) Arterial stiffening provides sufficient explanation for primary hypertension. PLoS Comput Biol 10(5):e1003634. https://doi.org/10.1371/journal.pcbi.1003634 CrossRefPubMedPubMedCentral

12.

Kaess BM, Rong J, Larson MG, Hamburg NM, Vita JA, Levy D, Benjamin EJ, Vasan RS, Mitchell GF (2012) Aortic stiffness, blood pressure progression, and incident hypertension. JAMA 308(9):875–881. https://doi.org/10.1001/2012.jama.10503 CrossRefPubMedPubMedCentral

13.

Ewen S, Ukena C, Linz D, Kindermann I, Cremers B, Laufs U, Wagenpfeil S, Schmieder RE, Bohm M, Mahfoud F (2015) Reduced effect of percutaneous renal denervation on blood pressure in patients with isolated systolic hypertension. Hypertension 65(1):193–199. https://doi.org/10.1161/HYPERTENSIONAHA.114.04336 CrossRefPubMed

14.

Mahfoud F, Bakris G, Bhatt DL, Esler M, Ewen S, Fahy M, Kandzari D, Kario K, Mancia G, Weber M, Bohm M (2016) Reduced blood pressure-lowering effect of catheter-based renal denervation in patients with isolated systolic hypertension: data from SYMPLICITY HTN-3 and the global SYMPLICITY registry. Eur Heart J. https://doi.org/10.1093/eurheartj/ehw325 CrossRefPubMedPubMedCentral

15.

Okon T, Rohnert K, Stiermaier T, Rommel KP, Muller U, Fengler K, Schuler G, Desch S, Lurz P (2016) Invasive aortic pulse wave velocity as a marker for arterial stiffness predicts outcome of renal sympathetic denervation. EuroIntervention 12(5):e684–692. https://doi.org/10.4244/EIJV12I5A110 CrossRefPubMed

16.

Fengler K, Rommel KP, Hoellriegel R, Blazek S, Besler C, Desch S, Schuler G, Linke A, Lurz P (2017) Pulse wave velocity predicts response to renal denervation in isolated systolic hypertension. J Am Heart Assoc. https://doi.org/10.1161/JAHA.117.005879 CrossRefPubMedPubMedCentral

17.

Stea F, Bozec E, Millasseau S, Khettab H, Boutouyrie P, Laurent S (2014) Comparison of the Complior Analyse device with Sphygmocor and Complior SP for pulse wave velocity and central pressure assessment. J Hypertens 32(4):873–880. https://doi.org/10.1097/HJH.0000000000000091 CrossRefPubMed

18.

Eftekhari A, Mathiassen ON, Buus NH, Gotzsche O, Mulvany MJ, Christensen KL (2011) Disproportionally impaired microvascular structure in essential hypertension. J Hypertens 29(5):896–905. https://doi.org/10.1097/HJH.0b013e3283447a1c CrossRefPubMed

19.

Al-Naamani N, Chirinos JA, Zamani P, Ruthazer R, Paulus JK, Roberts KE, Barr RG, Lima JA, Bluemke DA, Kronmal R, Kawut SM (2016) Association of systemic arterial properties with right ventricular morphology: the multi-ethnic study of atherosclerosis (MESA)-right ventricle study. J Am Heart Assoc. https://doi.org/10.1161/JAHA.116.004162 CrossRefPubMedPubMedCentral

20.

Quail MA, Steeden JA, Knight D, Segers P, Taylor AM, Muthurangu V (2014) Development and validation of a novel method to derive central aortic systolic pressure from the MR aortic distension curve. J Magn Reson Imaging 40(5):1064–1070. https://doi.org/10.1002/jmri.24471 CrossRefPubMed

21.

Quail MA, Short R, Pandya B, Steeden JA, Khushnood A, Taylor AM, Segers P, Muthurangu V (2017) Abnormal wave reflections and left ventricular hypertrophy late after coarctation of the aorta repair. Hypertension 69(3):501–509. https://doi.org/10.1161/HYPERTENSIONAHA.116.08763 CrossRefPubMed

22.

Chemla D, Hebert JL, Coirault C, Zamani K, Suard I, Colin P, Lecarpentier Y (1998) Total arterial compliance estimated by stroke volume-to-aortic pulse pressure ratio in humans. Am J Physiol 274(2 Pt 2):H500–505PubMed

23.

Martinez-Lemus LA (2012) The dynamic structure of arterioles. Basic Clin Pharmacol Toxicol 110(1):5–11. https://doi.org/10.1111/j.1742-7843.2011.00813.x CrossRefPubMed

24.

Hypertension EETFftMoA (2013) 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. J Hypertens 31(10):1925–1938. https://doi.org/10.1097/HJH.0b013e328364ca4c CrossRef

25.

Steeden JA, Atkinson D, Hansen MS, Taylor AM, Muthurangu V (2011) Rapid flow assessment of congenital heart disease with high-spatiotemporal-resolution gated spiral phase-contrast MR imaging. Radiology 260(1):79–87. https://doi.org/10.1148/radiol.11101844 CrossRefPubMedPubMedCentral

26.

Meinders JM, Hoeks AP (2004) Simultaneous assessment of diameter and pressure waveforms in the carotid artery. Ultrasound Med Biol 30(2):147–154. https://doi.org/10.1016/j.ultrasmedbio.2003.10.014 CrossRefPubMed

27.

Powalowski T, Pensko B (1988) A noninvasive ultrasonic method for the elasticity evaluation of the carotid arteries and its application in the diagnosis of the cerebro-vascular system. Arch Acoust 13(1–2):109–126

28.

Kelly R, Fitchett D (1992) Noninvasive determination of aortic input impedance and external left-ventricular power output—a validation and repeatability study of a new technique. J Am Coll Cardiol 20(4):952–963CrossRefPubMed

29.

Van Bortel LM, Balkestein EJ, van der Heijden-Spek JJ, Vanmolkot FH, Staessen JA, Kragten JA, Vredeveld JW, Safar ME, Boudier HAS, Hoeks AP (2001) Non-invasive assessment of local arterial pulse pressure: comparison of applanation tonometry and echo-tracking. J Hypertens 19(6):1037–1044. https://doi.org/10.1097/00004872-200106000-00007 CrossRefPubMed

30.

Muthurangu V, Atkinson D, Sermesant M, Miquel ME, Hegde S, Johnson R, Andriantsimiavona R, Taylor AM, Baker E, Tulloh R, Hill D, Razavi RS (2005) Measurement of total pulmonary arterial compliance using invasive pressure monitoring and MR flow quantification during MR-guided cardiac catheterization. Am J Physiol Heart Circ Physiol 289(3):H1301–1306. https://doi.org/10.1152/ajpheart.00957.2004 CrossRefPubMed

31.

O’Brien E, Parati G, Stergiou G, Asmar R, Beilin L, Bilo G, Clement D, de la Sierra A, de Leeuw P, Dolan E, Fagard R, Graves J, Head GA, Imai Y, Kario K, Lurbe E, Mallion JM, Mancia G, Mengden T, Myers M, Ogedegbe G, Ohkubo T, Omboni S, Palatini P, Redon J, Ruilope LM, Shennan A, Staessen JA, vanMontfrans G, Verdecchia P, Waeber B, Wang J, Zanchetti A, Zhang Y, European Society of Hypertension Working Group on Blood Pressure M (2013) European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens 31(9):1731–1768. https://doi.org/10.1097/HJH.0b013e328363e964 CrossRefPubMed

32.

Parati G, Stergiou G, O’Brien E, Asmar R, Beilin L, Bilo G, Clement D, de la Sierra A, de Leeuw P, Dolan E, Fagard R, Graves J, Head GA, Imai Y, Kario K, Lurbe E, Mallion JM, Mancia G, Mengden T, Myers M, Ogedegbe G, Ohkubo T, Omboni S, Palatini P, Redon J, Ruilope LM, Shennan A, Staessen JA, vanMontfrans G, Verdecchia P, Waeber B, Wang J, Zanchetti A, Zhang Y, European Society of Hypertension Working Group on Blood Pressure M, Cardiovascular V (2014) European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring. J Hypertens 32(7):1359–1366. https://doi.org/10.1097/HJH.0000000000000221 CrossRefPubMed

33.

Hulsen HT, Nijdam ME, Bos WJ, Uiterwaal CS, Oren A, Grobbee DE, Bots M (2006) Spurious systolic hypertension in young adults; prevalence of high brachial systolic blood pressure and low central pressure and its determinants. J Hypertens 24(6):1027–1032. https://doi.org/10.1097/01.hjh.0000226191.36558.9c CrossRefPubMed

34.

Mitchell GF, Lacourciere Y, Ouellet JP, Izzo JL Jr, Neutel J, Kerwin LJ, Block AJ, Pfeffer MA (2003) Determinants of elevated pulse pressure in middle-aged and older subjects with uncomplicated systolic hypertension: the role of proximal aortic diameter and the aortic pressure–flow relationship. Circulation 108(13):1592–1598. https://doi.org/10.1161/01.CIR.0000093435.04334.1F CrossRefPubMed

35.

O’Rourke MF, Nichols WW (2005) Aortic diameter, aortic stiffness, and wave reflection increase with age and isolated systolic hypertension. Hypertension 45(4):652–658. https://doi.org/10.1161/01.HYP.0000153793.84859.b8 CrossRefPubMed

36.

Segers P, Mahieu D, Kips J, Rietzschel E, De Buyzere M, De Bacquer D, Bekaert S, De Backer G, Gillebert T, Verdonck P, Van Bortel L, Asklepios i (2009) Amplification of the pressure pulse in the upper limb in healthy, middle-aged men and women. Hypertension 54(2):414–420. https://doi.org/10.1161/HYPERTENSIONAHA.109.133009 CrossRefPubMed

37.

O’Rourke MF, Hashimoto J (2007) Mechanical factors in arterial aging: a clinical perspective. J Am Coll Cardiol 50(1):1–13. https://doi.org/10.1016/j.jacc.2006.12.050 CrossRefPubMed

38.

DiBona GF (2005) Physiology in perspective: the wisdom of the body. Neural control of the kidney. Am J Physiol Regul Integr Comp Physiol 289(3):R633–641. https://doi.org/10.1152/ajpregu.00258.2005 CrossRefPubMed

39.

Reinecke M, Forssmann WG (1988) Neuropeptide (neuropeptide Y, neurotensin, vasoactive intestinal polypeptide, substance P, calcitonin gene-related peptide, somatostatin) immunohistochemistry and ultrastructure of renal nerves. Histochemistry 89(1):1–9CrossRefPubMed

40.

Krum H, Sobotka P, Mahfoud F, Bohm M, Esler M, Schlaich M (2011) Device-based antihypertensive therapy: therapeutic modulation of the autonomic nervous system. Circulation 123(2):209–215. https://doi.org/10.1161/CIRCULATIONAHA.110.971580 CrossRefPubMed

41.

Ewen S, Cremers B, Meyer MR, Donazzan L, Kindermann I, Ukena C, Helfer AG, Maurer HH, Laufs U, Grassi G, Bohm M, Mahfoud F (2015) Blood pressure changes after catheter-based renal denervation are related to reductions in total peripheral resistance. J Hypertens 33(12):2519–2525. https://doi.org/10.1097/HJH.0000000000000752 CrossRefPubMed

42.

Christensen KL, Buus NH (2012) Dissociation of blood pressure and resistance artery structure: potential clinical implications. Basic Clin Pharmacol Toxicol 110(1):73–79. https://doi.org/10.1111/j.1742-7843.2011.00799.x CrossRefPubMed

43.

Yano Y, Lloyd-Jones DM (2016) Isolated systolic hypertension in young and middle-aged adults. Curr Hypertens Rep 18(11):78. https://doi.org/10.1007/s11906-016-0686-x CrossRefPubMed

44.

Kandzari DE, Kario K, Mahfoud F, Cohen SA, Pilcher G, Pocock S, Townsend R, Weber MA, Bohm M (2016) The SPYRAL HTN global clinical trial program: rationale and design for studies of renal denervation in the absence (SPYRAL HTN OFF-MED) and presence (SPYRAL HTN ON-MED) of antihypertensive medications. Am Heart J 171(1):82–91. https://doi.org/10.1016/j.ahj.2015.08.021 CrossRefPubMed

45.

Stoiber L, Mahfoud F, Zamani SM, Lapinskas T, Bohm M, Ewen S, Kulenthiran S, Schlaich MP, Esler MD, Hammer T, Stensaeth KH, Pieske B, Dreysse S, Fleck E, Kuhne T, Kelm M, Stawowy P, Kelle S (2018) Renal sympathetic denervation restores aortic distensibility in patients with resistant hypertension: data from a multi-center trial. Clin Res Cardiol. https://doi.org/10.1007/s00392-018-1229-z CrossRefPubMedPubMedCentral

46.

Ohyama Y, Teixido-Tura G, Ambale-Venkatesh B, Noda C, Chugh AR, Liu CY, Redheuil A, Stacey RB, Dietz H, Gomes AS, Prince MR, Evangelista A, Wu CO, Hundley WG, Bluemke DA, Lima JA (2016) Ten-year longitudinal change in aortic stiffness assessed by cardiac MRI in the second half of the human lifespan: the multi-ethnic study of atherosclerosis. Eur Heart J Cardiovasc Imaging 17(9):1044–1053. https://doi.org/10.1093/ehjci/jev332 CrossRefPubMedPubMedCentral

47.

Wentland AL, Grist TM, Wieben O (2014) Review of MRI-based measurements of pulse wave velocity: a biomarker of arterial stiffness. Cardiovasc Diagn Ther 4(2):193–206. https://doi.org/10.3978/j.issn.2223-3652.2014.03.04 CrossRefPubMedPubMedCentral

Titel: Cardiac magnetic resonance assessment of central and peripheral vascular function in patients undergoing renal sympathetic denervation as predictor for blood pressure response
verfasst von: Karl Fengler
Karl-Philipp Rommel
Stephan Blazek
Maximilian Von Roeder
Christian Besler
Christian Lücke
Matthias Gutberlet
Jennifer Steeden
Michael Quail
Steffen Desch
Holger Thiele
Vivek Muthurangu
Philipp Lurz
Publikationsdatum: 09.05.2018
Verlag: Springer Berlin Heidelberg
Erschienen in: Clinical Research in Cardiology / Ausgabe 10/2018
Print ISSN: 1861-0684
Elektronische ISSN: 1861-0692
DOI: https://doi.org/10.1007/s00392-018-1267-6

Neu im Fachgebiet Kardiologie

19.04.2024 | Vorhofflimmern | Nachrichten

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Cardiac magnetic resonance assessment of central and peripheral vascular function in patients undergoing renal sympathetic denervation as predictor for blood pressure response

Abstract

Background

Methods

Results

Conclusions

Neu im Fachgebiet Kardiologie

Parodontalbehandlung verbessert Prognose bei Katheterablation

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Sind Betablocker auch für ältere herzschwache Personen nützlich?

Stillende Frauen haben geringeres kardiovaskuläres Risiko

Update Kardiologie

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Abstract

Background

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 10/2018

Binge drinking alcohol with caffeinated “energy drinks”, prolonged emesis and spontaneous coronary artery dissection: a case report, review of the literature and postulation of a pathomechanism

Cardiac sarcoidosis: a challenging diagnosis

Driving ability after right-sided puncture of the common femoral artery during coronary angiography

Association between central venous pressure as assessed by echocardiography, left ventricular function and acute cardio-renal syndrome in patients with ST segment elevation myocardial infarction

Expert opinion paper on atrial fibrillation detection after ischemic stroke

Sodium levels during hospitalization with acute myocardial infarction are markers of in-hospital mortality: Soroka acute myocardial infarction II (SAMI-II) project

Neu im Fachgebiet Kardiologie

Parodontalbehandlung verbessert Prognose bei Katheterablation

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Sind Betablocker auch für ältere herzschwache Personen nützlich?

Stillende Frauen haben geringeres kardiovaskuläres Risiko

Update Kardiologie